{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T23:54:37Z","timestamp":1793058877928,"version":"4.5.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,9]],"date-time":"2025-07-09T00:00:00Z","timestamp":1752019200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010978","name":"Wallonie-Bruxelles International","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010978","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100023447","name":"CHU Sainte-Justine Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100023447","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.ard.2025.07.005","type":"journal-article","created":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T11:15:39Z","timestamp":1753960539000},"page":"235-237","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Precision medicine and the chaos theory in rheumatoid arthritis"],"prefix":"10.1016","volume":"85","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9227-3820","authenticated-orcid":false,"given":"Cl\u00e9ment","family":"Triaille","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Durez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josef S.","family":"Smolen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iain B.","family":"McInnes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Lauwerys","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nisha","family":"Limaye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ard.2025.07.005_bib0001","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2020.102405","article-title":"Precision medicine and management of rheumatoid arthritis","volume":"110","author":"Aletaha","year":"2020","journal-title":"J Autoimmun"},{"issue":"1","key":"10.1016\/j.ard.2025.07.005_bib0002","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1136\/ard-2022-223356","article-title":"EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update","volume":"82","author":"Smolen","year":"2023","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.ard.2025.07.005_bib0003","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1136\/annrheumdis-2012-202361","article-title":"Forget personalised medicine and focus on abating disease activity","volume":"72","author":"Smolen","year":"2013","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.ard.2025.07.005_bib0004","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1002\/art.41516","article-title":"Multiomics and machine learning accurately predict clinical response to adalimumab and etanercept therapy in patients with rheumatoid arthritis","volume":"73","author":"Tao","year":"2021","journal-title":"Arthritis Rheumatol"},{"issue":"4","key":"10.1016\/j.ard.2025.07.005_bib0005","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1093\/rheumatology\/keab521","article-title":"Early prediction of clinical response to anti-TNF treatment using multi-omics and machine learning in rheumatoid arthritis","volume":"61","author":"Yoosuf","year":"2022","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"10.1016\/j.ard.2025.07.005_bib0006","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1186\/s13075-021-02567-y","article-title":"Machine learning model for identifying important clinical features for predicting remission in patients with rheumatoid arthritis treated with biologics","volume":"23","author":"Koo","year":"2021","journal-title":"Arthritis Res Ther"},{"issue":"13","key":"10.1016\/j.ard.2025.07.005_bib0007","doi-asserted-by":"crossref","first-page":"3890","DOI":"10.3390\/jcm13133890","article-title":"Machine learning prediction of treatment response to biological disease-modifying antirheumatic drugs in rheumatoid arthritis","volume":"13","author":"Salehi","year":"2024","journal-title":"J Clin Med"},{"issue":"6","key":"10.1016\/j.ard.2025.07.005_bib0008","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1136\/annrheumdis-2018-214539","article-title":"Synovial cellular and molecular signatures stratify clinical response to csDMARD therapy and predict radiographic progression in early rheumatoid arthritis patients","volume":"78","author":"Humby","year":"2019","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"10.1016\/j.ard.2025.07.005_bib0009","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1002\/gepi.22159","article-title":"Prediction of treatment response in rheumatoid arthritis patients using genome-wide SNP data","volume":"42","author":"Cherlin","year":"2018","journal-title":"Genet Epidemiol"},{"issue":"10271","key":"10.1016\/j.ard.2025.07.005_bib0010","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S0140-6736(20)32341-2","article-title":"Rituximab versus tocilizumab in anti-TNF inadequate responder patients with rheumatoid arthritis (R4RA): 16-week outcomes of a stratified, biopsy-driven, multicentre, open-label, phase 4 randomised controlled trial","volume":"397","author":"Humby","year":"2021","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.ard.2025.07.005_bib0011","doi-asserted-by":"crossref","first-page":"e648","DOI":"10.1016\/S2665-9913(23)00241-2","article-title":"Stratification of biological therapies by pathobiology in biologic-naive patients with rheumatoid arthritis (STRAP and STRAP-EU): two parallel, open-label, biopsy-driven, randomised trials","volume":"5","author":"Rivellese","year":"2023","journal-title":"Lancet Rheumatol"},{"issue":"2","key":"10.1016\/j.ard.2025.07.005_bib0012","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2022-002570","article-title":"Prediction of response to anti-TNF treatment using laboratory biomarkers in patients with rheumatoid arthritis: a systematic review","volume":"8","author":"Wientjes","year":"2022","journal-title":"RMD Open"},{"issue":"9","key":"10.1016\/j.ard.2025.07.005_bib0013","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/s41568-020-0265-y","article-title":"Tumour predisposition and cancer syndromes as models to study gene-environment interactions","volume":"20","author":"Carbone","year":"2020","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"10.1016\/j.ard.2025.07.005_bib0014","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/s41467-018-07932-1","article-title":"On chaotic dynamics in transcription factors and the associated effects in differential gene regulation","volume":"10","author":"Heltberg","year":"2019","journal-title":"Nat Commun"},{"issue":"24","key":"10.1016\/j.ard.2025.07.005_bib0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.cub.2023.11.002","article-title":"Chaos in a bacterial stress response","volume":"33","author":"Choudhary","year":"2023","journal-title":"Curr Biol"},{"key":"10.1016\/j.ard.2025.07.005_bib0016","series-title":"The fractal geometry of nature","first-page":"460","author":"Mandelbrot","year":"1982"},{"issue":"3","key":"10.1016\/j.ard.2025.07.005_bib0017","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1093\/rheumatology\/kead490","article-title":"Patterns and determinants of response to novel therapies in juvenile and adult-onset polyarthritis","volume":"63","author":"Triaille","year":"2024","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.ard.2025.07.005_bib0018","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1600-065X.2007.00501.x","article-title":"Oscillations in the immune system","volume":"216","author":"Stark","year":"2007","journal-title":"Immunol Rev"},{"issue":"1","key":"10.1016\/j.ard.2025.07.005_bib0019","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1186\/ar4146","article-title":"The role of the circadian clock in rheumatoid arthritis","volume":"15","author":"Gibbs","year":"2013","journal-title":"Arthritis Res Ther"},{"issue":"12","key":"10.1016\/j.ard.2025.07.005_bib0020","doi-asserted-by":"crossref","first-page":"3615","DOI":"10.1007\/s10067-022-06307-8","article-title":"Predictors of remission in rheumatoid arthritis patients treated with biologics: a systematic review and meta-analysis","volume":"41","author":"Khader","year":"2022","journal-title":"Clin Rheumatol"},{"issue":"2","key":"10.1016\/j.ard.2025.07.005_bib0021","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1136\/annrheumdis-2021-220853","article-title":"Baseline predictors of different types of treatment success in rheumatoid arthritis","volume":"81","author":"Capelusnik","year":"2022","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"10.1016\/j.ard.2025.07.005_bib0022","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1093\/rheumatology\/kew179","article-title":"Prediction of remission and low disease activity in disease-modifying anti-rheumatic drug-refractory patients with rheumatoid arthritis treated with golimumab","volume":"55","author":"Vastesaeger","year":"2016","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"10.1016\/j.ard.2025.07.005_bib0023","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s13075-017-1484-9","article-title":"Predictors of remission with etanercept-methotrexate induction therapy and loss of remission with etanercept maintenance, reduction, or withdrawal in moderately active rheumatoid arthritis: results of the PRESERVE trial","volume":"20","author":"Smolen","year":"2018","journal-title":"Arthritis Res Ther"},{"issue":"12","key":"10.1016\/j.ard.2025.07.005_bib0024","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1136\/ard-2023-224068","article-title":"Disease activity drives transcriptomic heterogeneity in early untreated rheumatoid synovitis","volume":"82","author":"Triaille","year":"2023","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.ard.2025.07.005_bib0025","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jbspin.2018.03.018","article-title":"Predictors of treatment response in rheumatoid arthritis","volume":"86","author":"Lequerr\u00e9","year":"2019","journal-title":"Joint Bone Spine"},{"issue":"12","key":"10.1016\/j.ard.2025.07.005_bib0026","doi-asserted-by":"crossref","DOI":"10.1016\/j.immuni.2024.11.004","article-title":"Synovial tissue myeloid dendritic cell subsets exhibit distinct tissue-niche localization and function in health and rheumatoid arthritis","volume":"57","author":"MacDonald","year":"2024","journal-title":"Immunity"},{"issue":"12","key":"10.1016\/j.ard.2025.07.005_bib0027","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1002\/art.42653","article-title":"Computer vision analysis of rheumatoid arthritis synovium reveals lymphocytic inflammation is associated with immunoglobulin skewing in blood","volume":"75","author":"Frezza","year":"2023","journal-title":"Arthritis Rheumatol"},{"issue":"7987","key":"10.1016\/j.ard.2025.07.005_bib0028","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1038\/s41586-023-06708-y","article-title":"Deconstruction of rheumatoid arthritis synovium defines inflammatory subtypes","volume":"623","author":"Zhang","year":"2023","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.ard.2025.07.005_bib0029","doi-asserted-by":"crossref","first-page":"2418","DOI":"10.1093\/rheumatology\/keae265","article-title":"Predictive factors and treatment outcomes associated with difficult-to-treat rheumatoid arthritis conditions: the ANSWER cohort study","volume":"63","author":"Watanabe","year":"2024","journal-title":"Rheumatology (Oxford)"}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496725042396?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496725042396?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T04:25:46Z","timestamp":1779942346000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003496725042396"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S0003496725042396"],"URL":"https:\/\/doi.org\/10.1016\/j.ard.2025.07.005","relation":{},"ISSN":["0003-4967"],"issn-type":[{"value":"0003-4967","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Precision medicine and the chaos theory in rheumatoid arthritis","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ard.2025.07.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V. on behalf of European Alliance of Associations for Rheumatology (EULAR).","name":"copyright","label":"Copyright"}]}}